OPKO To Hold Investor Conference

December 13, 2013 1:12pm EST

Download as PDF

MIAMI--(BUSINESS WIRE)--

OPKO Health, Inc. (NYSE: OPK) issued the following statement in response

to inquiries about a report issued by Lakewood Capital Management

challenging the potential of OPKO’s pipeline and business and investment

initiatives

We are aware of the report, which we believe is based on distorted and

inaccurate information. We continue to believe in our unique business

strategy and in the importance of OPKO’s therapeutic and diagnostic

product candidates. We are fully committed to developing and

commercializing our products and we look forward to updating investors

in a timely manner.

OPKO will host an investor conference on Tuesday morning, December 17,

2013 in New York City. The presentation will also be available by

webcast. Details for the presentation will be provided in a later

release.

ABOUT OPKO HEALTH, INC.

OPKO is a multinational biopharmaceutical and diagnostics company that

seeks to establish industry leading positions in large, rapidly growing

markets by leveraging its discovery, development and commercialization

expertise and novel and proprietary technologies. For more information,

visit http://www.opko.com .

SAFE HARBOR STATEMENT

This press release contains "forward-looking statements," as that

term is defined under the Private Securities Litigation Reform Act of

1995 (PSLRA), which statements may be identified by words such as

"expects," "plans," "projects," "will," "may," "anticipates,"

"believes," "should," "intends," "estimates," and other words of similar

meaning, including statements regarding the potential for our

therapeutic and diagnostic product candidates, as well as other

non-historical statements about our expectations, beliefs or intentions

regarding our business, technologies and products, financial condition,

strategies or prospects. Many factors could cause our actual activities

or results to differ materially from the activities and results

anticipated in forward-looking statements. These factors include those

described in our filings with the Securities and Exchange Commission, as

well as the risks inherent in funding, developing and obtaining

regulatory approvals of new, commercially-viable and competitive

products and treatments. In addition, forward-looking statements may

also be adversely affected by general market factors, competitive

product development, product availability, federal and state regulations

and legislation, the regulatory process for new products and

indications, manufacturing issues that may arise, patent positions and

litigation, among other factors. The forward-looking statements

contained in this press release speak only as of the date the statements

were made, and we do not undertake any obligation to update

forward-looking statements. We intend that all forward-looking

statements be subject to the safe-harbor provisions of the PSLRA.

OPKO Heath, Inc.

Steve D. Rubin, Executive Vice President –

Administration

Juan F. Rodrigez, Chief Financial Officer

+1

Source: OPKO Heath, Inc.

Released December 13, 2013

email Email Alerts

location_city Company Profile

contact_page Contacts

rss_feed RSS News Feed

account_tree Sitemap